SH2 domain-containing protein 3A (SH2D3A) Antibody (HRP)

Este producto es parte de SH2D - SH2 domain containing
Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
SH2 domain-containing protein 3A (SH2D3A) Antibody (HRP)
category
Primary Antibodies
provider
Abbexa
reference
abx349195
tested applications
ELISA

Description

SH2 domain-containing protein 3A (SH2D3A) Antibody (HRP) is a Rabbit Polyclonal antibody conjugated to HRP for the detection of Human SH2D3A.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
SH2 domain-containing protein 3A (SH2D3A)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G chromatography.
Size 1
50 µl
Size 2
100 µl
Size 3
200 µl
Size 4
1 ml
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9BRG2
Gene ID
10045
OMIM
604721
Alias
SH2D3A, NSP1, SH2 domain containing 3A
Background
Antibody anti-SH2D3A
Status
RUO

Descripción

SH2D3A, also known as NSP1 (novel SH2-containing protein 1), is an adaptor protein containing an SH2 domain and a proline-rich region that mediates interactions with signaling molecules in receptor tyrosine kinase pathways. It is involved in regulating actin cytoskeletal remodeling, cell adhesion, and migration by linking signaling proteins like Crk-associated substrates (CAS) to downstream effectors. SH2D3A plays a key role in integrin-mediated signaling and growth factor receptor activation, particularly during cell motility and adhesion processes. It is highly expressed in tissues undergoing dynamic changes, such as embryonic development and wound healing. Dysregulation of SH2D3A has been linked to cancer progression, where it promotes metastasis and invasion through actin cytoskeletal reorganization and integrin activation. Knockout studies reveal defects in cell migration, adhesion, and spreading, underscoring its importance in cellular movement and signal transduction.

Related Products

FNab07822

anti- SH2D3A antibody

May play a role in JNK activation.

Ver Producto
abx115505

Sh2 Domain Containing 3A (SH2D3A) Antibody

Sh2 Domain Containing 3A Antibody is a Rabbit Polyclonal antibody against Sh2 Domain Containing 3A.

Ver Producto
abx237822

SH2 Domain Containing 3A (SH2D3A) Antibody

SH2D3A Antibody is a Rabbit Polyclonal against SH2D3A.

Ver Producto